Merck Press Releases

Merck Press Releases Distributed by EIN Presswire

• Published on September 28, 2011 - 18:46 GMT

  SMi's Pharmaceutical m-Health conference

  /EINPresswire.com/SMi Group is delighted to announce their Pharmaceutical m-Health conference. To be held on the 10th and 11th October 2011, the conference will address the numerous ways in which the pharmaceutical industry can contribute to, and benefit …

  Distribution channels: Companies, World & Regional ...
• Published on September 27, 2011 - 13:10 GMT

  Merck Names Cuong Viet Do as Chief Strategy Officer

  WHITEHOUSE STATION, N.J., Sept. 27, 2011 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the appointment of Cuong Viet Do as chief strategy officer, effective Oct. 3, 2011. As chief strategy officer, Do, 45, will be …

  Distribution channels: Companies
• Published on September 20, 2011 - 12:12 GMT

  Merck Joins Global Fight to Help Save Women's Lives During Pregnancy and Childbirth

  NEW YORK, N.Y., September 20, 2011 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that it will join United Nations (UN) Secretary-General Ban Ki-moon and heads of state at the UN later today to launch "Merck for …

  Distribution channels: Companies
• Published on September 20, 2011 - 08:10 GMT

  New Data on Odanacatib, Merck's Phase III Investigational Cat-K Inhibitor for Osteoporosis, Presented at the Annual Meeting of The ...

  SAN DIEGO, Sept. 19, 2011 - New clinical and pre-clinical data on Merck's odanacatib, an investigational cathepsin K (cat-K) inhibitor for the treatment of osteoporosis in post-menopausal women, were presented at the 33 rd Annual Meeting of The …

  Distribution channels: Companies
• Published on April 15, 2011 - 12:12 GMT

  Merck and Johnson & Johnson Reach Agreement on Distribution Rights for REMICADE® and SIMPONI®

  WHITEHOUSE STATION, N.J., and NEW BRUNSWICK, N.J., April 15, 2011 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Johnson & Johnson (NYSE: JNJ) and its subsidiary Centocor Ortho Biotech Inc., today announced that the …

  Distribution channels: Companies
• Published on March 31, 2011 - 20:10 GMT

  New Data Analyses with VICTRELIS™ (boceprevir), Merck's Investigational Medicine, Examined Possible Predictors of Sustained ...

  BERLIN, March 31, 2011 - Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced results from several new data analyses from the pivotal Phase III studies evaluating the addition of its investigational oral protease …

  Distribution channels: Companies
• Published on March 31, 2011 - 13:10 GMT

  VICTRELIS™ (boceprevir), Merck's Investigational Medicine, Added to Peginterferon Alfa-2a and Ribavirin Achieved ...

  BERLIN, March 31, 2011 - Merck (NYSE: MRK), known as MSD outside of the United States and Canada, reported that final results from a Phase III study of VICTRELIS ™ (boceprevir), its investigational oral hepatitis C protease inhibitor, added to …

  Distribution channels: Companies
• Published on March 25, 2011 - 08:10 GMT

  HASH(0xa6b74a0)

  WHITEHOUSE STATION, NJ, March 24, 2011 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved an expanded age indication for ZOSTAVAX ® (Zoster …

  Distribution channels: Companies
• Published on March 9, 2011 - 13:12 GMT

  Merck Announces FDA Acceptance of New Drug Application for Investigational Ophthalmic Medication SAFLUTAN® (tafluprost)

  WHITEHOUSE STATION, N.J., March 9, 2011 -- Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the New Drug Application (NDA) for SAFLUTAN ® (tafluprost), Merck's investigational preservative-free …

  Distribution channels: Companies
• Published on March 7, 2011 - 17:10 GMT

  Merck Announces New Data Analyses for VICTRELIS™ (Boceprevir) will be Presented at The International Liver Congress™ / ...

  WHITEHOUSE STATION, N.J., March 7, 2011 - Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that several new data analyses from Phase III studies of VICTRELIS ™ (boceprevir), its investigational oral …

  Distribution channels: Companies
• Published on February 14, 2011 - 17:17 GMT

  Merck Wins First FOSAMAX ® (alendronate sodium) State Court Trial

  WHITEHOUSE STATION, N.J., Feb. 14, 2011 - Merck & Co., Inc. today said a state court jury in New Jersey found in its favor in the Rosenberg v. Merck case, rejecting the claims of a woman who blamed her dental and jaw related problems on her FOSAMAX use …

  Distribution channels: Companies
• Published on January 18, 2011 - 15:13 GMT

  Statement on FOSAMAX® (alendronate sodium) Product Liability Trial in New Jersey State Court

  WHITEHOUSE STATION, N.J., Jan. 18, 2011 - Merck will vigorously defend itself in a jury trial set to begin today in the Superior Court for Atlantic County, New Jersey. The company believes the evidence will show that FOSAMAX did not cause the plaintiff to …

  Distribution channels: Companies
• Published on July 9, 2010 - 06:11 GMT

  Leading California Immigration Attorney Goes On Record Against Arizona Immigration Senate Bill 1070

  Riverside County based immigration defense attorney Carlos Batara takes on immigration policies in his blog as an ardent advocate for immigrants' rights. Southern California--Leading Southern California Immigration Attorney Carlos Batara recently …

  Distribution channels: Consumer Goods, World & Regional ...
• Published on June 29, 2010 - 15:45 GMT

  Merck Challenges Verdict in Fosamax Trial

  WHITEHOUSE STATION, N.J., June 25, 2010 - Merck & Co., Inc. today said it is challenging the decision returned by a New York jury in the retrial of a federal FOSAMAX case, Boles v. Merck. This case was the Plaintiffs' Steering Committee's top …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on June 29, 2010 - 15:41 GMT

  Sheltering Arms South Awarded Prestigious Accreditation for Stroke Care

  Sheltering Arms Hospital, Central Virginia's premier physical rehabilitation healthcare provider, has received a 'Disease-Specific Care Certification' in Stroke Rehabilitation through The Joint Commission for its hospital in south Richmond. …

  Distribution channels: Companies, World & Regional ...
• Published on June 25, 2010 - 12:25 GMT

  Merck, Cardiome Get Marketing Approval for Brinavess

  WHITEHOUSE STATION, N.J. and VANCOUVER, CANADA, June 25, 2010 -- Merck (NYSE:MRK) and Cardiome Pharma Corp. (NASDAQ: CRME/ TSX: COM) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on April 7, 2010 - 12:56 GMT

  Nevada Governor Bypasses Attorney General to Sue Feds over Healthcare

  April 7, 2010 - Nevada Gov. Jim Gibbons wanted his state to join a lawsuit filed by more than a dozen states to sue the federal government over the new healthcare legislation. State Attorney General Catherine Cortez Masto declined to include Nevada as part …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on March 29, 2010 - 08:19 GMT

  Limo Broker launches Wedding Car Hire Brokerage Website

  Wedding Car Hire Brokerage Website Unveiled as the Latest Addition to the Limo Broker Chain The UK's leading limo hire provider, Limo Broker (http://www.limobroker.co.uk/), has just unveiled its latest venture. WeddingCarHire.co.uk is the most …

  Distribution channels: Automotive Industry, Consumer Goods ...
• Published on March 16, 2010 - 12:07 GMT

  Merck Boosts Lobbying Expenses by 38 pct

  Merck Boosts Lobbying Expenses by 38 pct March 16, 2010 /EIN PRESSWIRE/ To have its voice heard in the healthcare debate, Merck & Co. boosted its lobbying efforts by 38% to $1.8 million in Q4 2009, the Associated Press reports. Merck lobbied …

  Distribution channels: Consumer Goods, World & Regional ...